Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Hepato-Biliary-Pancreatic Sciences|December 2, 2022
Central pancreatectomy prevents postoperative diabetesRosa Klotz, Constanze Schilling, Charlotte Kuner, et al.
Langenbeck'S Archives of Surgery|December 29, 2017
Percutaneous versus surgical strategy for tracheostomy: a systematic review and meta-analysis of perioperative and postoperative complicationsRosa Klotz, Pascal Probst, Marlene Deininger, et al.
Annals of Surgery|June 27, 2022
Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic CancerThomas Hank, Ulla Klaiber, Ulf Hinz, et al.
Langenbeck'S Archives of Surgery|December 7, 2025
Diarrhea after pancreatic surgery is associated with the extent of resection: a single-center retrospective cohort-studyCharlotte Gustorff, Carl-Stephan Leonhardt, Jakob Mühlbacher, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 24, 2019
Randomized Trial of Pylorus-Preserving vs. Pylorus-Resecting Pancreatoduodenectomy: Long-Term Morbidity and Quality of LifeUlla Klaiber, Pascal Probst, Felix J Hüttner, et al.
Langenbeck'S Archives of Surgery|January 9, 2021
Meta-analysis of primary open versus closed cannulation strategy for totally implantable venous access port implantationUlla Klaiber, Pascal Probst, Matthes Hackbusch, et al.
Oncotarget|January 11, 2020
Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinomaLi Xie, Leizhou Xia, Ulla Klaiber, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 4, 2019
Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survivalUlrike Heger, Huihui Sun, Ulf Hinz, et al.
Pilot and Feasibility Studies|December 15, 2016
Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trialSusanne Blank, Phillip Knebel, Georg-Martin Haag, et al.
BMJ Open|September 4, 2020
Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce postoperative pancreatic fistula after distal pancreatectomy: the PREBOT<i>Pilot</i> trialUlla Klaiber, Peter Sauer, Eike Martin, et al.
Pageof 7